Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | ||||||||||
| Net income from continuing operations | 30.17%15.82M | -104.76%-84K | -197.04%-2.36M | 1,004.64%37.82M | 186.88%21.47M | 751.10%12.16M | 486.62%1.76M | 239.87%2.43M | 6.14%3.42M | 460.25%7.49M |
| Other non cashItems | -85.16%-8.46M | -256.45%-776K | 160.11%2.13M | 1,664.73%3.77M | 274.56%11.38M | -167.69%-4.57M | 48.95%496K | -339.68%-3.54M | -150.84%-241K | -9,975.76%-6.52M |
| Change in working capital | 182.68%2.33M | -203.85%-2.29M | -39.85%-4.19M | -2,400.00%-50K | 453.87%6.52M | -134.36%-2.82M | 79.41%-753K | -181.47%-3M | -100.07%-2K | 142.05%1.18M |
| -Change in receivables | 330.89%2.39M | -10.04%-1.25M | -147.83%-2.52M | -376.27%-2.45M | -64.24%742K | 62.48%-1.04M | 36.41%-1.14M | -130.27%-1.02M | -40.68%885K | 232.00%2.08M |
| -Change in other current assets | 71.20%630K | -64.25%-1.48M | -37.56%-835K | -228.60%-589K | -34.06%548K | -65.09%368K | -27.20%-898K | 15.81%-607K | -33.24%458K | 107.75%831K |
| -Change in other current liabilities | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cash from discontinued operating activities | ||||||||||
| Operating cash flow | 72.03%12.7M | -105.54%-227K | 2.88%-1.55M | 120.73%18.01M | 55.67%8.12M | 19.00%7.38M | 605.67%4.1M | 34.79%-1.6M | 139.77%8.16M | 3,509.15%5.22M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Net PPE purchase and sale | 29.50%-3.58M | -143.69%-3.65M | 34.86%-2.21M | -47.70%-13.68M | -17.91%-3.73M | -70.20%-5.07M | 0.20%-1.5M | -108.69%-3.39M | 51.29%-9.26M | -131.41%-3.16M |
| Net business purchase and sale | --0 | ---- | ---- | --0 | --0 | --0 | ---- | ---- | 4,697.97%15.86M | 3,558.26%11.93M |
| Dividends received (cash flow from investment activities) | ---- | ---- | ---- | --0 | --0 | --0 | --0 | --0 | -1.41%1.05M | --0 |
| Net other investing changes | -58.39%-25.92M | -58.65%-24.75M | -72.03%-20.32M | -106.72%-67.35M | -302.75%-23.58M | -52.56%-16.36M | -93.09%-15.6M | -49.04%-11.81M | -51.13%-32.58M | 8.66%-5.86M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -37.60%-29.49M | -61.09%-27.54M | -48.22%-22.52M | -225.00%-81.04M | -1,036.81%-27.31M | -119.33%-21.43M | -78.49%-17.1M | -78.83%-15.2M | 32.30%-24.93M | 157.20%2.92M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | ||||||||||
| Net issuance payments of debt | 15.19%16.36M | 142.02%33.38M | 55.20%25.38M | 248.30%63.04M | 336.51%18.69M | 336.46%14.2M | 15.91%13.79M | 50.78%16.35M | -9.25%18.1M | -255.03%-7.9M |
| Net commonstock issuance | --0 | -4,933.93%-5.64M | -8,338.46%-1.1M | 91.57%-125K | --0 | --0 | 87.89%-112K | 91.10%-13K | 60.74%-1.48M | -13.25%-282K |
| Net other financing activities | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 15.19%16.36M | 102.79%27.75M | 48.61%24.29M | 278.61%62.91M | 328.36%18.69M | 354.48%14.2M | 24.65%13.68M | 52.72%16.34M | 3.24%16.62M | -268.81%-8.18M |
| Net cash flow | ||||||||||
| Beginning cash position | -14.31%994K | 114.08%1.02M | -12.92%809K | -14.77%929K | 33.20%1.31M | -18.65%1.16M | -43.40%476K | -14.77%929K | -94.08%1.09M | -34.14%982K |
| Current changes in cash | -393.92%-435K | -103.65%-25K | 146.36%210K | 25.47%-120K | -841.51%-499K | 133.33%148K | 16.92%684K | -81.93%-453K | 99.07%-161K | 86.78%-53K |
| End cash position | -57.26%559K | -14.31%994K | 114.08%1.02M | -12.92%809K | -12.92%809K | 33.20%1.31M | -18.65%1.16M | -43.40%476K | -14.77%929K | -14.77%929K |
| Free cash from | 293.99%9.11M | -248.81%-3.88M | 24.60%-3.76M | 490.96%4.32M | 113.77%4.39M | -28.32%2.31M | 212.68%2.6M | -22.34%-4.98M | 92.92%-1.11M | 235.29%2.06M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.